Regulatory Document Publishing

Introduction

Features

Core Learning Areas

Related Courses

Who should attend

The Advanced Certification in Regulatory Document Publishing by Royed Training is a specialized online program that prepares future-ready regulatory professionals. It provides a clear, step-by-step understanding of how global regulatory submissions are prepared, published, and managed across the pharmaceutical, biopharmaceutical, and medical device industries.

To begin with, the course introduces the fundamentals of regulatory affairs and explains the vital role of regulatory document in global drug development. As learners progress, they gradually move into the practical aspects of authoring, reviewing, and managing CMC documentation for multiple international markets. This structured flow ensures that participants understand ICH guidelines, CTD/eCTD formats, Quality Overall Summaries (QOS), and region-specific submission expectations with ease.

Furthermore, the curriculum covers essential concepts related to lifecycle management, variations, renewals, and regulatory query handling. These sections help learners understand how regulatory submissions evolve throughout a product’s lifecycle and how publishing teams ensure accuracy, compliance, and completeness.

Additionally, the course highlights how Artificial Intelligence is transforming regulatory document preparation and publishing. Learners gain practical exposure to AI-driven tools for dossier automation, structured content creation, labeling harmonization, error detection, and data integrity improvement. As the industry moves toward digital and automated submissions, this knowledge becomes essential for regulatory careers.

Moreover, learners participate in real-world case studies, simulations, and capstone projects, which make the concepts easier to understand and apply. These activities help bridge the gap between theoretical knowledge and the day-to-day responsibilities of regulatory publishing professionals.

As a result, participants develop dual expertise:

A strong foundation in global regulatory document publishing and eCTD submissions.
The ability to apply AI tools for faster, smarter, and more accurate regulatory document preparation and publishing.

Course Snapshots:

Course Code: RYD-141
Title of the course: Advanced Certification in Regulatory Document Publishing.
Duration: 1 Month; can be free extendable upto 3 month.
Nature of the course: Online learning course. So the course can be accessed online anywhere 24×7.
Eligibility : Graduation in any discipline. Even final year graduation students can apply.
Course Certificate: Certificate will be provided at the end of the successful completion of the course.

This online course utilizes interactive learning tools to guide each participant through the steps of CMC Writing process for different regulatory bodies and practical exposure in pre and post submission management. The course is designed to challenge students to apply what they have learned through the use of interactive exercises, reflection questions, expert live chat and a final assessment at the end of the course.

Features of the Course:

Blends technical publishing, regulatory strategy, and AI application—a combination rarely available in traditional programs.
Designed for practical use, with real submission templates, pull-through examples, and publishing-ready exercises.
Built for future readiness as global regulators move toward structured content, digitized submissions, and next-generation eCTD standards.
Ideal for RA professionals, publishing specialists, CMC writers, QA professionals, and anyone transitioning to regulatory operations roles.

1. AI-Powered Authoring & Publishing Workflows

Participants will learn how next-generation AI tools are transforming regulatory operations by improving document accuracy, accelerating compilation, ensuring version control, and enabling structured content creation. The program teaches practical usage of AI for:

Content drafting and QC
Consistency checks
Metadata structuring
Lifecycle management (LOR, LOAs, variations, renewals)
Submission-ready formatting and conversion

2. End-to-End Regulatory Document Preparation

A complete orientation to preparing compliant regulatory documents across markets (US FDA, EMA, MHRA, Health Canada, TGA, PMDA, GCC, ASEAN, and India). The program covers:

CTD and eCTD document structure
Module-wise document authoring expectations
Required metadata, granularity, bookmarking, and hyperlinking
Readiness checks using standardized publishing tools

3. Advanced Regulatory Publishing Techniques

Master the technical publishing functions used in industry:

eCTD Publishing
NeeS and Non-eCTD format
ESG and CESP gateway submissions
Sequence creation and lifecycle operations
PDF optimization, validation, and compliance checks
Indexing, stitching, and final packaging for submission

4. Submission Management & Strategy

Hands-on learning to navigate the full submission lifecycle:

Submission planning and timelines
Dataset and document flow management
Regional submission requirements
interfacing with cross-functional teams (RA, QA, CMC, Clinical, PV)
Responding to regulatory queries, deficiencies, and RFI workflows
Monitoring and managing sequence lifecycle across variations, renewals, annual reports, and supplemental submissions

5. Understanding eCTD Components and Technical Requirements

A practical orientation to:

eCTD Modules 1–5
Regional granularity matrices
DTD & Schema basics
Using validation tools and resolving errors
Tracking and maintaining submission sequences over the lifecycle

6. Types of Regulatory Submissions

The course covers preparation and publishing workflows for:

IND, NDA, ANDA, BLA, DMF, IMPD, MAA
Variations (Type IA, IB, II), Renewals
Supplements and Amendments
Annual & Periodic Reports
Drug Master File submissions (US, EU, ASEAN, India)
Pre- and post-approval submissions

7. Simulation-Based Learning

Every section includes hands-on simulations, such as:

Creating an eCTD sequence
Publishing a full Module 3
Performing hyperlinking/bookmarking correctly
Running validation tools and interpreting results
Preparing a variation sequence
Compiling a complete submission package for a mock regulatory filing

8. Case Studies: Real-World Regulatory Challenges

Learners will work through:

Failed submissions and how to prevent them
Lifecycle management cases (multiple variations, renewals in parallel)
Gateway submission failures and troubleshooting
AI-driven efficiency improvement case examples
Publishing compliance errors and remediation techniques

Some related courses

Regulatory Submission training content is also part of the International Drug Regulatory Affairs (EPGIDRA) and Drug Biologic Medical Device Regulatory Affairs (PGDBMRA) course. Therefore, a separate course is not required if you already taking EPGIDRA or PGDBMRA course.

This program is ideal for professionals who want to advance their careers in regulatory affairs and CMC documentation while mastering AI-powered tools:

‍Regulatory Affairs Professionals – seeking to enhance their dossier preparation and submission skills.
CMC Writers & Technical Authors – aiming to improve their expertise in Module 3 authoring and QOS preparation.
Pharma & Biopharma R&D Professionals – who need to understand regulatory documentation requirements.
Quality Assurance & Compliance Managers – focusing on data integrity, lifecycle management, and regulatory expectations.
AI & Digital Transformation Enthusiasts – interested in applying AI/ML, NLP, and automation tools in regulatory processes.
Graduates & Postgraduates in Life Sciences/Pharmacy – aspiring to build a career in global regulatory affairs.

Section 1Global Drug Discovery & Fundamentals of Regulatory Publishing

Lecture 1Introduction to drug discovery, Regulatory Documents and Publishing

Lecture 2Investigational New Drug Application (INDA)

Lecture 3New Drug Application (NDA)

Lecture 4Basic concept and understanding of the Generic Drug

Lecture 5Abbreviated New Drug Application (ANDA) Filing

Lecture 6Exploratory IND Vs. Traditional IND

Lecture 8USFDA expedited programs

Lecture 9EMA and EMA Authorisation Process

Lecture 10EU MA Procedure - Centralised, Decentralised, Mutual Recognition, National Procedure

Lecture 11IMPD | Significance | Format of IMPD | Differences with CTA, IB, IND

Lecture 12Investigator’s Brochure | Significance | Format of IB | Preparing different sections of IB

Lecture 13Data Exclusivity and Market Protection - Supplementary Patent Protection, Exclusivity, 6/10 Rule, 8+2+1 Formulae

Lecture 14Introduction to Regulatory Publishing | eCTD | NeSS | Regulatory Submission Workflow | Key Competencies Required for Regulatory Publishing Professionals

Lecture 15Overview of Global Regulatory Agencies and how their expectations impact regulatory publishing and submission workflows

Lecture 16Types of Regulatory Documents | Implications from regulatory publishing point of view

Lecture 17Regulatory vs Cross-Functional Documents | Document Ownership Mapping | Document Workflow: From Authoring to Submission

Lecture 19Characteristics of Module-Specific Documents | How Publishing Ensures Document Integrity | Common Document Errors & How Publishing Detects Them

Lecture 20Cross Functional Review Mechanism

Lecture 21Best Practices CFD Review

Lecture 22Regulatory Publishing Collaboration Workflow

Section 2Regulatory Requirements for Clinical Studies

Lecture 23Understanding on Clinical Trials and Clinical Research

Lecture 24Clinical Trial Protocol Writing

Lecture 25Ethics in Clinical Research

Lecture 26Informed Consent | Practical Training on preparing ICF | Ready Templates

Section 3ICH Guideline

Lecture 27Introduction to ICH | Members | Guidelines

Lecture 28ICH Q1 : Stability Guideline | Matrixing | Bracketing

Lecture 29ICH Q2 : Analytical Validation

Lecture 30ICH Q3 : Impurities

Lecture 31Rest of ICH Q Family Guidelines

Section 4Managing CMC requirements

Lecture 33Chemistry, Manufacturing & Controls

Lecture 34Fundamental of CMC | Detailed understanding of CMC section writing | Important Points regarding CMC | Drug Product and Drug Substance | Excipient, FP, Analysis and Stability Study Requirements

Lecture 35505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA

Lecture 36Advance Learning on 505B2 Pathway

Lecture 37EU MA Application Types and Strategic Planning

Section 5Compiling Dossier Preparation

Lecture 38Introduction to Common Technical Document (CTD)

Lecture 39CMC Dossier & Compliance Management

Lecture 40Key Consideration for Drug Master File Preparation and Submission

Lecture 41Practical Understanding on Drug Master File Preparation and Submission

Lecture 42Associated Learning: Site Master File - Detailed Understanding

Lecture 43Drug Master File - Fees

Lecture 44Drug Master File - Global Perspective [Across Different Regions]

Lecture 45Electronic Common Technical Document (ECTD)

Lecture 46Certificate of Analysis

Lecture 47Asean Common Technical Document (ACTD)

Lecture 48Grouped Submission | Significance | Importance in Market Access and Regulatory point of view | Case Study

Lecture 49Developing Module 1 Structured Diagram | US EU LATAM GCC ASEAN INDIA JAPAN CHINA | Leaf Structuring

Lecture 52Regulatory Publishing scenario-based assessment on CTA, IND, NDA, BLA, MAA, Annual Reports, and Variations

Section 6Regulatory Document Submission and Management

Lecture 53FDA Forms and How to fill the resources

Lecture 54Strategic Discussion: PreIND, EOP1, EOP2 - What to expect !

Lecture 55Importance of effective dossier management

Lecture 56Discussion on 85 common deficiencies in CTD submission dossier

Lecture 57Detailed Understanding on ANDA Submission Dossier

Lecture 58Prior Approval Submission

Lecture 59Detailed Understanding on ANDA Fees

Lecture 60Detailed Understanding on 505(b)(2) VS. Suitability Petition : Case Based Learning

Lecture 61NCE Vs. 505b2 application - Case Based Learning

Lecture 62FTF - 180 Days Exclusivity - Case Based Learning

Lecture 63Classic case study of the 505b2 filing : Case Based Learning

Lecture 64EU MA Strategic Planning: Full, Full-mixed, hybrid applications. Generic, Similar biologic application pathway, Well-established use application, Fixed combination application, Informed consent application

Lecture 65Supplemental New Drug Application (sNDA) | Filing and Submission Management | Requirements | Best Practices | Different Forms for sNDA submissions

Lecture 66OGD Table - How to Prepare | Sample Tabular Summary Preparation

Section 7Stability Study

Lecture 67Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study

Lecture 68

Lecture 69Stability Zone Finder

Lecture 70Stability Studies : Case discussions

Lecture 71Stability Data for Zone IV countries

Lecture 72Accelerated and intermediate testing conditions

Lecture 73Long Term Stability Testing Requirements

Lecture 74Stability Study Protocol Development - Dosage form: Capsule

Lecture 75Stability Data Sheet

Lecture 76Dossier Stability Test

Lecture 77Testing Frequency

Lecture 78Bracketing

Lecture 79Matrixing

Section 8BA BE Study

Lecture 80PKPD in Drug Discovery | PK-PD trial | Understanding PKPD from regulatory perspective in drug approval process

Lecture 81Bioequivalence Study | Study design | Different types of BE Studies

Lecture 83Biopharmaceutical Classification System (BCS) | Types | Biowaivers | BCS tool for drug development and regulatory submission

Lecture 84Bioequivalence Study - Discussion - Timeline of stability study and bioequivalence study

Lecture 85Bioequivalence Study - Discussion - Dissolution Testing

Lecture 86Bioequivalence Study - Generic Approval and Additives Labeling Requirements

Lecture 87BA BE Study Design | Comparing different types of the study design

Lecture 882wco Study Design | Design Table | Importance

Lecture 893wco Study Design | Design Table | Importance

Lecture 90FRCO Study Design | Design Table | Importance

Lecture 91OGD Table - How to Prepare | Sample Tabular Summary Preparation

Section 9Post Approval Changes and Variation Management

Lecture 92Variation Management | Reasons for Variation | Working in Variation Department

Lecture 93Variation Classification | Basis of Classification | US and EU Variation Classification | Other region variation guideline

Lecture 94EU variation -Types, Requirement & Planning - IA, IAIN, IB, II ; US FDA Variation AR, CBE-0, CBE-30, PAS - Strategic Discussion | Similarities & Differentiation

Lecture 95Impact Assessment in CMC Writing | Case Based Discussion| Scenario Decision Making

Section 10Quality Issues | Post Filing Regulatory Queries | Response to Queries (RTQs) | Critical Issues in Submission Management

Lecture 96Data Integrity issues in Pharmaceutical Industry : Detailed Understanding

Lecture 97Establishment Inspection Report | 483 Observations | USFDA Warning Letter | Handling of FDA inspection | Closing of Warning Letter

Lecture 98Electronic Batch Record for effective compliance management | Key Understanding | Functionalities | Importance in managing data integrity

Lecture 99RTQs | Response to Queries | How to handle Regulatory Queries

Section 11Biologic CMC Requirements

Lecture 100Biosimilar Development Process

Lecture 101Strategic Consideration for Biosimilar Development

Lecture 103Studies required for approval of biosimilar

Lecture 104Comparability of Biologics | Different Categories of Comparability | General Principles

Section 12Differentiating CMC and Regulatory Writing with Medical and Scientific Writing

Lecture 105Introduction to Medical Writing | Objective | Significance | Medical Writing Vs. Scientific Writing | Key Notes

Lecture 106Types of Medical Writing | Regulatory Writing | CMC Writing | Clinical Writing | Documents under each class of medical writing

Lecture 107Ethical Consideration of Medical Writing | Important Considerations | Effective strategies for each ethical consideration | Case studies

Lecture 108Regulatory Documents | Classification of regulatory documents | Understanding of each class of documents | Ethical consideration for Regulatory Writing

Lecture 109Publication Writing and Regulatory Writing | Key Differences with Examples

Lecture 110Regulatory Writing - Review Test

Lecture 111Hands on Case Study Protocol Designing for Experimental Asthma Drug | Analysis of various aspect of protocol | Open File

Lecture 112Drafting of Study Objective Methodology and Endpoint | Checklist

Section 13Reference | Discussions | CMC Case Studies

Lecture 113Comparison of Requirement of Various Regulatory Bodies

Lecture 114Comparison of Dossier Requirements of Europe and US

Lecture 115Comparison of DMF requirement of various regulatory bodies

Lecture 116ICH Guidelines - Comprehensive View

Lecture 117ICH CTD Top Level View with Notes and Explanation

Lecture 118Comparison of ICH US EU CTD

Lecture 119Regulatory Documents - At a glance

Lecture 120Structured CMC Writing Checklist

Lecture 121CMC Writing Case Study | Successful Documentation

Lecture 122Structure for CMC Writing | Understanding 3.2.S and 3.2.P section | Documents requirements | Case Study

Lecture 123Well written Vs. Poorly Written CMC Section | Practical Example

Lecture 124Drug Substance Section in CMC | Documentations | Practical Examples | Do’s and Don’ts

Lecture 125Example of Well-Written Drug Substance Characterization | Impurities and Degradation Products | Well-Written Impurities and Degradation Products | Synthesis and Manufacturing Processes | Control of Drug Substance (Specifications, Testing, and Acceptance Criteria)

Lecture 126Stability Studies and Data Presentation in CMC Writing | Case Based Analysis of Stability Study Data Presentation | Interpretation of stability data

Lecture 127Certificate of Suitability (CEP) | Significance | Importance | Understanding Regulatory Compliance and Submission Process | Walkthrough

Lecture 128CEP Dossier DMF - Differences

Lecture 129Developing Specifications for a New API

Lecture 130Example of Manufacturing Process and Controls

Lecture 131Interpretation of Stability Table

Lecture 132Critical Stability Scenarios | 8 Different Case Studies | Stability Study - Outcome based action plan creation

Lecture 133Critical Stability Issues - Database | Implication | Action Plan

Lecture 134Policy 0070 | RPDP Submission and Management timeline | Anonymisation Report (AnR) - Significance | AnR in FRDP

Lecture 135Common Pitfalls in CMC Writing and How to Avoid Them | Case Study

Lecture 136Process Validation Report (PVR) | Sample Process Validation Report Analysis | CPPs and CQAs identification

Lecture 137Case Study - Omissions of CPPs in PVR | Case insight, explanation, action plan | Correlations - CPPs - CQAs - IPCs

Lecture 138Binding and Non-binding legal considerations - Module 3 Quality in CMC Section | Case Studies

Lecture 139Binding and Non-binding Scenarios with Examples

Section 14WHO Certification Scheme | Documentation

Lecture 140Introduction to Certificate of Pharmaceutical Product | Types of CoPP | List of Countries / Regulatory Authorities who requires CoPP | CoPP as a part of generic market expansion planning

Lecture 141WHO-GMP Certification Scheme

Lecture 142Template of Certificate of Pharmaceutical product | Key observations and points to note while working on CoPP

Lecture 143WHO Prequalification Status : Significance | Strategic Importance | Submission Process | WHO PQ Documentation | Case study on WHO PQ submission management

Lecture 144WHO EML Vs. WHO PQ | Significance | Importance in Market Access and Regulatory point of view

Section 15Fundamental of AI in CMC Documentation

Lecture 145Introduction to AI

Lecture 146Basics of AI ML DL | Key Differences | Application in industry

Lecture 147Types of AI

Lecture 148AI Project | Overview

Lecture 149Comprehensive Training on AI Project | Managing Stages | AI Iteration

Lecture 150How machine learning

Lecture 151Understanding Regulatory Affairs – Traditional vs. Digital | 2 Case Study

Lecture 152Basics of AI for Regulatory Professionals | Understanding different models used in RA | Case Study | Simulation

Lecture 153AI Application across drug life cycle | Case Analysis | Model predictions

Lecture 154AI Terms with Regulatory Significance | Regulatory Applications

Lecture 155NLP in Regulatory Affairs | Conceptual understanding | Usage | NLP in Labeling

Lecture 156Data Grouping with Unsupervised Learning | Case Simulation | Hands on Exercise

Lecture 157Quality Data and Bias | Bias in datasets | Different Types of Bias in Pharma Datasets

Lecture 158AI Data Quality Standard | Checklist

Lecture 159Download AI Data Quality Checklist

Lecture 160Case Study: Accelerated Approval Using Real-World Evidence AI

Lecture 161AI Model for Dossier Submission and Filing - Model Selection | Simulation

Lecture 162AI Technologies in RA

Lecture 163Structured Vs. Unstructured Data | Practical Understanding | Explore Patient Datasets

Lecture 164Sample Data Exercise | Data error | Data Refinement and Cleaning of the data

Section 16AI in Regulatory Authoring and Regulatory Document Publishing

Lecture 165AI-Powered Regulatory Document Authoring and CMC Writing

Lecture 166AI Tools Comparison - Authoring and CMC Writing (Module 2 & 3)

Lecture 167Tips for Selecting AI Tools (CMC Authoring)

Lecture 168CMC - AI Workflow Checklist | Simulation Based Cases

Lecture 169HITL Regulatory Document Authoring

Lecture 170Confidence Score in Regulatory Authoring | Case Simulation in CMC Authoring

Lecture 171Confidence Scores in Data Extract in Regulatory Writing [Case Simulation]

Section 17eCTD v4.0 and Publishing Advanced Training

Lecture 172eCTDV4.0 Fundamental Understanding | Structures | Key Features

Lecture 173eCTDV4.0 Structure | Lifecycle Management

Lecture 174eCTD Validation | Managing Validation | Tool Types | Types of Error | Validation Error Management

Lecture 175eCTD Validation Tools

Lecture 176eCTD Publishing Cycle

Lecture 177HL7 - Structure and Understanding in the context of eCTD V4.0

Lecture 178Tips and Submission Readiness Checklist

Lecture 179eCTD Submission Checklist Format

Lecture 180Regulatory Publishing Document Control Challenges

Lecture 181Document Control Checklist

Lecture 182Leaf Structure Analysis | Common Error in Leaf Structuring

Lecture 183Formatting Rules Templated and Agency Specification

Lecture 184Versioning for Regulatory Publishing

Lecture 185File Naming Standard

Lecture 186Text Recognition and Optical Character Recognition (OCR)

Lecture 187Versioning File Naming OCR - How they work together

Lecture 188Final Document Assembly

Lecture 189Visual Diagram : eCTD Structure and XML Hierarchy

Lecture 190TOC and CI Management

Lecture 191Initial Submission & Maintenance Submission

Lecture 192Managing Lifecycle Operators - NEW REPLACE DELETE APPEND

Lecture 193eCTD Dossier Lifecycle - Multi Sequence View

Lecture 19410 Year eCTD Lifecycle : Sequence Evolution Diagram - Sequence Management Simulation

Lecture 195Global Decision Tree - Classifying Post Approval Changes

Lecture 196eCTD Technical Validation | Typical issues | Resolutions

Lecture 197eCTD Validation Readiness Checklist

Lecture 198QC Checklist Design and Pre Submission Review

Lecture 199Submission Gateway | FDA ESG • EMA CESP • Health Canada Portal • PMDA Gateway

Lecture 200Regulatory Publishing Simulation

Lecture 201Pre-Gateway Submission Review Checklist | Post Submission Confirmation

Section 18Risk and Compliance Management

Lecture 202AI and Data Integrity | Regulatory Documentation | Case Based Learning | Understanding Data Integrity Principles | Application and Use Cases

Lecture 203Cases of data breaches with explanation

Lecture 204Case Based Discussion : Data Breach in AI-Assisted CMC Drafting

Section 19CCDS - Labelling and Artwork Management

Lecture 205CCDS Management

Lecture 206CCDS Management Tools - Native, AI Plus | Key Functionalities

Lecture 207AI Augmented Labelling Compliance System

Lecture 208Label Drift in CCDS Management | Simulation Case Study | AI Based Workflow in Label Drift detection and management

Lecture 209AI Review of Labels, PI and SMPC with help of the Case Based Simulation | 4 Case Simulations

Lecture 210CCDS Management Case Study | Pregnancy Warning Upgrade Case Study

Lecture 211CCDS Management Case Study | Dosage Section Conflict | Case Based Analysis

Lecture 212Centralized Artwork Operation | Mechanism | Operation Step Planning

Lecture 213Case Study on Centralized Artwork Operation [Recall Management]

Lecture 214Artwork Management Terms | Key Understanding on Terminologies | Usage in Artwork Cases

Section 20Real World Evidence and Real World Data | Strategic Decision Making

Lecture 215Evidence Based Decision Making | Combine evidences for decision making | Do we need more evidence?

Lecture 216RWD and RWE | Potential sources of RWE | Traditional RCTs vs. RWE | Case Study - RWE Programs | Influencing HCP decision-making

Lecture 217RWD and RWE in Product Lifecycle Management

Lecture 218RWD and RWE - Fit to use | Assessment

Lecture 219RWD data sources | Different types | Detailed understanding of each class

Lecture 220RWD Study Design

Lecture 221RWE Published Tool | Insights on commonly used tools

Lecture 222Healthcare Reimbursement Models : Value Based Care | Fee for Service (FFS) Model | Other Reimbursement Models

Lecture 223Consensus Narrative Review

Lecture 224Electronic Patient Data | EMR | EHR | Differences | Software architecture and characteristics

Lecture 226RWD Characteristics

Lecture 227RCT vs. RWE Comparison | Case Based Analysis

Lecture 228RCT and RWE Comparison

Section 21Working on Healthcare Datasets

Lecture 229Introduction to Healthcare Datasets

Lecture 230Dataset 1: Claims Data (Insurance)

Lecture 231Dataset 2: Retail Pharmacy Prescription Data

Lecture 232Dataset 3: Longitudinal Patient Data

Lecture 233Characteristics of Different Set of Healthcare Data

Lecture 234Reimbursement and Pricing Datasets

Lecture 235RWE Data Sources & Quality Considerations Checklist | Case Based Analysis

Lecture 236Triangulation and benchmarking | Enhancing Data Validation Through Cross-Referencing

Lecture 237RWD & RWE Case Database

Lecture 238RWE Large Dataset for Data Crunching Exercises |Data cleaning & preprocessing | Comparative Effectiveness Analysis

Section 22AI Tools, Ethics and Future Landscape

Lecture 239AI Reg Tools - Review | Understanding Capabilities

Lecture 240Regulatory Authority View on AI Adoption

Section 23Course Certification

Lecture 241Final Certification Examination

Lecture 242Request for Course Certificate

publishing regulatory documents, regulatory document publishing, regulatory document submission

Regulatory Document Publishing

Download All Course Catalogue

Your form has been submitted

Request for Course Demo Session

Your form has been submitted

Introduction

Features

Core Learning Areas

Related Courses

Who should attend

Course Snapshots:

Features of the Course:

1. AI-Powered Authoring & Publishing Workflows

2. End-to-End Regulatory Document Preparation

3. Advanced Regulatory Publishing Techniques

4. Submission Management & Strategy

5. Understanding eCTD Components and Technical Requirements

6. Types of Regulatory Submissions

7. Simulation-Based Learning

8. Case Studies: Real-World Regulatory Challenges

Some related courses

Royed Training

Regulatory Document Publishing

Please sign in first

Not a member?

Download All Course Catalogue

Your form has been submitted

Request for Course Demo Session

Your form has been submitted

Introduction

Features

Core Learning Areas

Related Courses

Who should attend

Course Snapshots:

Features of the Course:

1. AI-Powered Authoring & Publishing Workflows

2. End-to-End Regulatory Document Preparation

3. Advanced Regulatory Publishing Techniques

4. Submission Management & Strategy

5. Understanding eCTD Components and Technical Requirements

6. Types of Regulatory Submissions

7. Simulation-Based Learning

8. Case Studies: Real-World Regulatory Challenges

Some related courses